Main content start

What's Happening Events

24
Nov 2023
(Fri)

The roles of Next Generation Sequencing (NGS) testing in searching for targeted drugs and immune drugs for treatment of cancer patients

Subject
Medical Sciences

Thanks for your participation!

The above event has been completed successfully. Please look forward to the upcoming events.

Want to read more about the event recap?

Date & time
24Nov 2023 (Fri)13:00 - 14:00
Venue
🔷【In-person】: Room 204, 2/F, Admiralty Centre, 18 Harcourt Road, Admiralty, HK 🔷【Online】: HKU SPACE YouTube Channel
Fee
Free
Speaker
  • Dr Timothy Yip

Dr Timothy Yip

Senior Medical Science Adviser, ACT Genomics (HK) Ltd. & Visiting Professor, University of Missouri-Columbia, USA

Enquiry
(kwkman@hkuspace.hku.hk)
Relevant Programmes
Higher Certificate in Medical Laboratory Science MSc in Biomedical Science B.Sc.(Hons.) in Biological Science Diploma in Laboratory Science
moreRelevant Programmes

NGS testing is widely used to find genetic changes in the tumors to look for suitable targeted drugs in cancer treatment. Further newer generation of drugs such as antibody drugs conjugate (ADC) and immune drugs can be used to help the patients when cancer relapse develops due to drug resistance to the first generation of drugs. We are anticipating cancer diseases can be converted into chronic diseases with patients having long term survival in the future.